EDMONTON, Alberta--(BUSINESS WIRE)--NanoSpeed is pleased to announce that they have appointed an exclusive European distributor for their 25-OH Vitamin D deficiency test kit - Test4D™ following the announcement last week that Test4D™ is CE marked and registered for sale in the European Union. AKSA Medical is an independent distributor based in the Benelux specializing in the sale of in-vitro diagnostics and point of care testing.
“To accommodate rapidly growing interest in NanoSpeed’s Test4D™ product in Europe, we have entered into this distributor agreement with AKSA Medical,” said Dr. Seema Gupta, President of NanoSpeed Diagnostics, Inc., a leading diagnostics company focused on providing portable, innovative and rapid testing solutions. “AKSA Medical is a leading clinical laboratory and diagnostics distributor dedicated to delivering value to their clients and to patients. We are pleased that AKSA Medical has chosen to distribute Test4D™ and we welcome them to our global distribution network.”
Test4D™ is a patented and unique point-of-care test that provides information on Vitamin D deficiency within 10 minutes. This test requires only a single drop of blood from the patient and costs 90% less when compared to other standard or conventional tests.
Test4D™ is not approved for commercial use in Canada or the United States and is limited by federal law to research or investigational use only.
About AKSA Medical
AKSA Medical is an independent medical
testing distributor based in the Benelux providing equipment and
products ranging from routine laboratory assays to point-of-care
testing. Since 2008, AKSA Medical has positioned itself to be a
recognized and leading distributor of high quality testing products in
Europe.
For more information, please visit www.aksamedical.com.
About NanoSpeed Diagnostics Inc.
NanoSpeed, incorporated in
2009, develops proprietary diagnostic/screening test kit platforms based
on their Lateral Flow Immuno Assay and Lab-on-a-Chip technologies. These
technological advancements provide patients with cost effective and
reliable testing tools that will address the increasing needs of the
healthcare industry, regulatory agencies and consumers.
About Vitamin D deficiency and Test4D™:
Vitamin D deficiency
is a common problem in Canada, where 60% of adults have suboptimal
levels of 25-OH vitamin D. Vitamin D deficiency has been associated with
abnormalities in absorption of calcium, phosphorus, and bone metabolism;
cardiovascular disease; diabetes; cancer; osteomalacia and osteoporosis
in adults; and rickets in children. Deficient vitamin D levels are
typically the result of an inadequate intake of vitamin D through
sunlight, diet, or supplements, or due to malabsorptive disorders.
25-OH vitamin D levels are currently measured through laboratory testing. Over the past decade, there has been an incremental surge in the demand for vitamin D testing, resulting in increasing costs to government supported healthcare systems. An alternative to laboratory testing is Point-of-Care-Testing (POCT), medical testing that occurs outside of a clinical laboratory and near the patient. Potential advantages of POCT include reduction in errors and costs to the healthcare system, and the provision of quick clinical diagnoses.
To address the demands of vitamin D testing, NanoSpeed Diagnostics Inc. developed Test4D™, a POCT device for the qualitative detection of 25-OH Vitamin D in human blood obtained via fingertip puncture.
Test4D™ is available for commercial sale through certain distributors, or can be purchased for research purposes directly from NanoSpeed.
